Alnylam Pharmaceuticals | ALNY - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 195.44B 5.55B 2026-06
Arrowhead Research USD 11.5B 2.72B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Incyte USD 22.65B 3.92B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
Sarepta Therapeutics USD 1.9B 388M 2026-06
Takeda JPY 8.2T 809.7B 2026-06
Tectonic Therapeutic USD 580M 190M 2026-03
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06
Xencor USD 1.19B 301M 2026-06